MYP_061866
Basic Information
m1 /Ser1
Antimicrobial
Antiviral
Antiviral Anti-HIV
Antiviral Antiviral mechanism Viral entry inhibition
Standard
18 amino acids
C97H150N26O25S
Standard
Sequence
AKVNGQSGRMEFFWTILK
Physicochemical Analysis
2112.45 Da
9.99
1.80
1.60
0.0998
-0.23
0.29
0.04
18.42
65.00
0.1667
5500.00
5500.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
851.69
-6.47
30.0
28.0
71.0
149.0
4.0
19.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0073194 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Antiviral
Pseudovirus influenza A virus(HA(VN/04)/HIV)
RECORD: Rec_0111996 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Antiviral
RECORD: Rec_0337365 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Protein-derived synthetic peptide
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Anti-HIV Entry inhibition
Pseudovirus influenza A virus (HA (VN/04)/HIV)
30 μM
% inhibition
Mammalian: 4.4 h; Yeast: >20 h; E. coli: >10 h